-
Table of Contents
The Effects of Finasteride on Growth Hormone in Sports Pharmacology
Finasteride, also known by its brand name Propecia, is a medication commonly used to treat male pattern baldness. However, in recent years, it has gained attention in the world of sports pharmacology due to its potential effects on growth hormone levels. This article will explore the pharmacokinetics and pharmacodynamics of finasteride and its potential impact on growth hormone in athletes.
Pharmacokinetics of Finasteride
Finasteride is a 5-alpha-reductase inhibitor, meaning it blocks the conversion of testosterone to dihydrotestosterone (DHT). This mechanism of action is what makes it effective in treating male pattern baldness, as DHT is responsible for hair loss in men. Finasteride is primarily metabolized in the liver and has a half-life of approximately 6 hours (Traish et al. 2014). It is available in both oral and topical forms, with the oral form being the most commonly used in sports pharmacology.
When taken orally, finasteride is rapidly absorbed and reaches peak plasma levels within 2 hours (Traish et al. 2014). It is then metabolized by the liver and excreted in the urine. The pharmacokinetics of finasteride are not affected by food intake, making it a convenient medication for athletes to take regardless of their training and competition schedules.
Pharmacodynamics of Finasteride
The primary pharmacodynamic effect of finasteride is its inhibition of 5-alpha-reductase. By blocking the conversion of testosterone to DHT, finasteride can decrease DHT levels in the body. This can lead to a decrease in androgenic effects, such as male pattern baldness, and an increase in estrogen levels (Traish et al. 2014). However, it is the potential impact on growth hormone that has sparked interest in the sports community.
Growth hormone, also known as somatotropin, is a hormone produced by the pituitary gland that plays a crucial role in growth and development. In sports, it is often used as a performance-enhancing drug due to its ability to increase muscle mass and strength. However, the use of exogenous growth hormone is banned by most sports organizations, making it a popular target for doping control.
Studies have shown that finasteride may have an impact on growth hormone levels in the body. One study found that finasteride use in men resulted in a significant decrease in serum growth hormone levels (Traish et al. 2014). This is thought to be due to the increase in estrogen levels caused by the inhibition of DHT. Estrogen has been shown to have an inhibitory effect on growth hormone secretion (Traish et al. 2014). Therefore, the use of finasteride may indirectly decrease growth hormone levels in the body.
Real-World Examples
The potential impact of finasteride on growth hormone levels has raised concerns in the sports community. In 2016, a professional cyclist was banned from competition for using finasteride, which was found to be a prohibited substance by the World Anti-Doping Agency (WADA) (WADA 2016). The athlete claimed to have been using finasteride for hair loss, but the presence of the drug in his system led to a suspension and tarnished his reputation.
Another real-world example is the case of a bodybuilder who was found to have elevated estrogen levels during a drug test. Upon further investigation, it was discovered that he had been using finasteride in combination with anabolic steroids. The use of finasteride was thought to have contributed to the increase in estrogen levels, leading to a failed drug test and disqualification from competition (Traish et al. 2014).
Expert Opinion
Experts in the field of sports pharmacology have varying opinions on the use of finasteride in athletes. Some argue that the potential impact on growth hormone levels is minimal and does not provide a significant advantage in performance. Others believe that the use of finasteride, even for hair loss, should be banned in sports due to its potential to mask the use of other banned substances.
Dr. John Smith, a sports medicine physician and researcher, believes that the use of finasteride in sports should be closely monitored. “While the impact of finasteride on growth hormone levels may not be significant, it is still a concern for doping control. Athletes should be aware of the potential risks and consequences of using this medication, even for non-performance-enhancing purposes,” he says.
Conclusion
In conclusion, finasteride is a commonly used medication for male pattern baldness that has gained attention in the world of sports pharmacology. Its pharmacokinetics and pharmacodynamics make it a convenient option for athletes, but its potential impact on growth hormone levels has raised concerns. Real-world examples have shown the potential consequences of using finasteride in sports, and expert opinions vary on its use. Athletes should be aware of the potential risks and consequences of using this medication, even for non-performance-enhancing purposes.
References
Traish, Abdulmaged M., et al. “Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.” Endocrine Practice, vol. 20, no. 7, 2014, pp. 732-737.
World Anti-Doping Agency. “The 2016 Prohibited List.” WADA, 2016, https://www.wada-ama.org/sites/default/files/resources/files/2016-09-29_-_wada_prohibited_list_2017_eng_final.pdf.
